Efficacy, Safety and Cost Analyses in Ulcerative Colitis Patients Undergoing Granulocyte and Monocyte Adsorption or Receiving Prednisolone

BMC Gastroenterology - United Kingdom
doi 10.1186/1471-230x-13-41
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Single Needle Granulocyte and Monocyte Apheresis for Ulcerative Colitis: A Retrospective Safety Analysis

Kurume Medical Journal
Medicine
2020English

EFFICACY AND SAFETY OF TOFACITINIB IN ULCERATIVE COLITIS (Review)

Koloproktologia
2018English

Changes in the Plasma Level of Macrophage Migration Inhibitory Factor in Ulcerative Colitis Patients Treated With Selective Granulocyte and Monocyte Apheresis

Internal Medicine
Internal MedicineMedicine
2007English

Preparation of Chondroitin Sulfate-Glycyl-Prednisolone Conjugate Nanogel and Its Efficacy in Rats With Ulcerative Colitis

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2019English

Efficacy and Safety of Biologic Agents and Tofacitinib in Moderate-To-Severe Ulcerative Colitis: A Systematic Overview of Meta-Analyses

United European Gastroenterology Journal
OncologyGastroenterology
2019English

Ulcerative Colitis Accompanied by Pyoderma Gangrenosum Successfully Treated With Granulocyte Monocyte Apheresis : A Case Report

Progress of Digestive Endoscopy
2017English

Efficacy and Safety of Ezetimibe in Patients Undergoing Hemodialysis

Endocrine Journal
EndocrinologyMetabolismDiabetes
2010English

Long-Term Safety of Adalimumab in Clinical Trials in Adult Patients With Crohn's Disease or Ulcerative Colitis

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate to Severe Ulcerative Colitis

Gastroenterology
HepatologyGastroenterology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy